Prevalence and characteristics of a family history of EndStage renal disease among adults in the United States population: Reasons for Geographic and Racial Differences in Stroke (REGARDS) renal cohort study

被引:36
作者
McClellan, William
Speckman, Rebecca
McClure, Leslie
Howard, Virginia
Campbell, Ruth C.
Cushman, Mary
Audhya, Paul
Howard, George
Warnock, David G.
机构
[1] Emory Univ, Georgia Med Care Fdn, Dept Med, Div Renal, Atlanta, GA 30329 USA
[2] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA
[3] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
[4] Univ Alabama Birmingham, Div Nephrol, Dept Biostat, Birmingham, AL 35294 USA
[5] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA
[6] Univ Vermont, Coll Med, Dept Med, Burlington, VT 05405 USA
[7] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA
[8] Amgen Corp, Thousand Oaks, CA 91320 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2007年 / 18卷 / 04期
关键词
D O I
10.1681/ASN.2006090952
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
This report describes the prevalence and characteristics of people with a family history of ESRD in a first-degree relative (FH-ESRD). This is a cross-sectional study of individuals in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort, a population-based sample of US residents who are 45 yr and older. FH-ESRD was ascertained at baseline among 12,030 participants of the cohort, and multivariate logistic regression was used to identify characteristics that were independently associated with FH-ESRD. FH-ESRD was reported by 9.5% of participants. Individual characteristics that were independently associated with FH-ESRD included black race (odds ratio [OR] 2.14; 95% confidence interval [CII 1.82 to 2.53); female gender (OR 1.28; 95% Cl 1.08 to 1.51); a history of diabetes (OR 1.22; 95% Cl 1.02 to 1.47); a 1-SD change in the log of the C-reactive protein level (OR 1.10; 95% CI 1.01 to 1.19); and World Health Organization body mass index weight categories normal (OR 2.11; 95% CI 0.66 to 6.79), overweight (OR 2.64; 95% Cl 0.82 to 8.42), and obese (OR 3.48; 95% Cl 1.09 to 11.1) compared with underweight. Black but not white individuals with FH-ESRD were more likely to have an estimated GFR < 60 ml/min per 1.73 m(2). There is a high prevalence of FH-ESRD among US adults, and the prevalence of FH-ESRD was higher among lack individuals. Individuals with a positive family history were more likely to have diabetes and to be obese. If confirmed, then these findings suggest that individuals with FH-ESRD may benefit from interventions to improve the detection and treatment of chronic kidney disease risk factors such as diabetes and obesity.
引用
收藏
页码:1344 / 1352
页数:9
相关论文
共 47 条
[1]   Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease [J].
Bergman, S ;
Key, BO ;
Kirk, KA ;
Warnock, DG ;
Rostand, SG .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (03) :341-346
[2]  
Brown WW, 2003, KIDNEY INT S, V83, pS50
[3]  
*CDC, 2002, EP INF 2002 DAT STAT
[4]   The metabolic syndrome and chronic kidney disease in US adults [J].
Chen, J ;
Muntner, P ;
Hamm, LL ;
Jones, DW ;
Batuman, V ;
Fonseca, V ;
Whelton, PK ;
He, J .
ANNALS OF INTERNAL MEDICINE, 2004, 140 (03) :167-174
[5]   Angiotensin-converting enzyme inhibition and renal protection in nondiabetic patients: The data of the meta-analyses [J].
Chiurchiu, C ;
Remuzzi, G ;
Ruggenenti, P .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 :S58-S63
[6]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[7]   Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III) [J].
Clase, CM ;
Garg, AX ;
Kiberd, BA .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (05) :1338-1349
[8]   Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey [J].
Coresh, J ;
Astor, BC ;
Greene, T ;
Eknoyan, G ;
Levey, AS .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (01) :1-12
[9]   Erythropoiesis-stimulating protein therapy and the decline of renal function: a retrospective analysis of patients with chronic kidney disease [J].
Dean, BB ;
Dylan, M ;
Gano, A ;
Knight, K ;
Ofman, JJ ;
Levine, BS .
CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (07) :981-987
[10]   The natural history of chronic renal failure:: Results from an unselected, population-based, inception cohort in Sweden [J].
Evans, M ;
Fryzek, JP ;
Elinder, CG ;
Cohen, SS ;
McLaughlin, JK ;
Nyrén, O ;
Fored, CM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (05) :863-870